Form 4: Olema Pharma CEO Gifts 8,500 Shares to Charity

Olema Pharmaceuticals' President and CEO, Sean Bohen, reported a gift of 8,500 shares of common stock to a charitable donor advised fund.

Summary

• Sean Bohen, President and CEO of Olema Pharmaceuticals, Inc. and a Director, gifted 8,500 shares of the company's common stock.
• The transaction occurred on December 26, 2025.
• The shares were gifted to a charitable donor advised fund at a price of $0 per share.
• Following this transaction, Sean Bohen beneficially owns 237,650 shares of Olema Pharmaceuticals common stock.
• This total includes 4,488 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025.

Sentiment

Score: 5

Explanation: A neutral event. The gift of shares is a personal transaction by an executive and does not directly impact the company's operations or financial health. It represents a minor reduction in direct insider ownership but is offset by the philanthropic nature.

Positives

• Demonstrates philanthropic activity by a key executive.

Negatives

• A slight reduction in the direct beneficial ownership of common stock by the President and CEO.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This is a routine insider transaction, common across all industries for executives managing personal holdings or engaging in philanthropy. It does not reflect on broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal direct impact. A very slight reduction in direct insider ownership, but the overall beneficial ownership remains substantial.
• Employees, Customers, Suppliers, Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction involving a gift of shares for philanthropic purposes. It does not provide any new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is a personal matter for the executive and does not reflect a change in confidence in the company. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on existing company fundamentals.

Keywords

Olema Pharmaceuticals, OLMA, Sean Bohen, Form 4, Insider Transaction, Stock Gift, Charitable Donation, CEO, Director, Common Stock